What Fridays does

Fridays (operated by Thrive Health Group Inc., headquartered in Irvine, California) is a direct-to-consumer telehealth platform that delivers GLP-1 weight loss care and adjacent wellness services to US adults. The core offering combines compounded and brand-name GLP-1 medications (Semaglutide, Tirzepatide, Zepbound, Ozempic) with virtual eligibility assessment, licensed-provider consultations, prescription management, coaching, dietitian support, and bundled lab testing through Quest Diagnostics, all delivered through a web patient portal and native iOS and Android apps. Clinical services are provided through partner network OpenLoop Healthcare Partners PC, and medications are fulfilled by a four-state network of regulated compounding pharmacies (RedRock, Health Warehouse, Precision Medicine, Triad Rx).

The platform has expanded beyond weight loss into three additional verticals: a Longevity program built on NAD+, Sermorelin, MIC-B12, and nasal spray formulations; a Testosterone Replacement Therapy program offering Testosterone Cypionate and Enclomiphene with biomarker baseline testing; and a GLP-1 Microdosing program for lower-dose protocols targeting energy, cravings, and mood. This vertical extension broadens the addressable consumer base beyond traditional weight-loss candidates into wellness, men's health, and micro-optimization segments.

The business model is a recurring monthly or discounted four-month subscription that bundles clinical consultations, prescription management, coaching, lab testing, and medication coordination, with optional add-ons such as meal prep and mental health coaching. Customer acquisition runs through SEO-optimized educational content, social media (Instagram, TikTok, Facebook, YouTube, Snapchat), email and SMS, paid promotions via discount codes (FORBES, EXPERTISE, SHOP100), and a creator/affiliate program. The company reports 115,000+ members, 4,000+ Trustpilot reviews rated Excellent, and internal figures of 9 lb average first-month weight loss and 15.28% body weight reduction at 12 months, with no disclosed revenue, funding, or founding date.

Name

Fridays

Legal name

Thrive Health Group Inc.

Website

https://joinfridays.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Fridays is a US direct-to-consumer telehealth platform operated by Thrive Health Group Inc. that delivers GLP-1 weight loss medications, longevity therapies, testosterone replacement, and microdosing protocols to adults 18+ through virtual provider consultations and bundled monthly subscriptions.

Ownership category

akta.pro rank

Product category

Telehealth Weight Loss and Wellness Services

NAICS

Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH)

akta.pro secondary industry

Medication Adherence, Reminders & Patient Support (HLACAKAF)

Keywords

• GLP-1 weight loss
• Telehealth medication services
• Weight management programs
• Compounded semaglutide medications
• Longevity wellness treatments

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Marketing or Sales, Personnel, Operations, Technology or R&D, Supply Chain

Revenue model

1. Subscription Services: Monthly subscription model providing access to clinical consultations, prescription management, coaching, lab testing, and medication coordination. Includes monthly visits with licensed clinicians, weekly group coaching sessions, personalized nutritionist support, and care coaching. Medication costs are included in the program subscription. Subscription automatically renews unless canceled.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels11 records

Core offering

Fridays operates a virtual telehealth platform that connects U.S. consumers with licensed healthcare providers for evaluation, prescription, and ongoing management of GLP-1 weight loss medications (compounded and brand-name semaglutide and tirzepatide), as well as longevity peptides, testosterone replacement therapy, and GLP-1 microdosing protocols. The subscription bundles clinical consultations, prescription management, dietitians, live workouts, support groups, mental health coaching, and lab testing through a digital patient portal, with medication fulfillment handled by a network of state-regulated compounding pharmacies.

Product overview

Fridays is a holistic telehealth weight loss and wellness platform built around GLP-1 receptor agonist medications and lifestyle coaching. The core offering is the GLP-1 Weight Loss Program, which pairs compounded medications (Semaglutide, Tirzepatide) and FDA-approved brands (Zepbound, Ozempic) with dietitians, live workouts, support groups, mental health coaching, and a patient portal. The platform extends into three related verticals: the Longevity Program (NAD+, Sermorelin, MIC-B12, nasal spray), the Testosterone Replacement Therapy program (Testosterone Cypionate, Enclomiphene), and the GLP-1 Microdosing program for sub-standard-dose users seeking energy and cravings management. All programs are delivered through licensed telehealth providers via the Fridays Patient Portal (app.joinfridays.com), with medications fulfilled through a network of state-regulated compounding pharmacies.

Differentiator

Problem solved

Functional benefit

Products and services

• GLP-1 Weight Loss Program The flagship telehealth subscription offering GLP-1 receptor agonist medications (compounded and brand-name) for chronic weight management, combined with dietitians, live workouts, support groups, mental health coaching, optional meal prep, monthly provider visits, and insurance concierge support. Targeted at U.S. adults seeking sustainable weight loss.
• Compounded Semaglutide A compounded GLP-1 receptor agonist medication containing semaglutide as the active ingredient, prepared by state-regulated compounding pharmacies and prescribed through Fridays for weight management. Customizable dosing is available.
• Compounded Tirzepatide A compounded dual GLP-1/GIP receptor agonist medication containing tirzepatide as the active ingredient, prepared by state-regulated compounding pharmacies and prescribed through Fridays for weight management.
• Zepbound FDA-approved tirzepatide (dual GLP-1/GIP receptor agonist) brand-name medication for chronic weight management, made available through the Fridays program when prescribed by a licensed provider.
• Ozempic (Semaglutide) FDA-approved semaglutide (GLP-1 receptor agonist) brand-name medication for type 2 diabetes, available off-label through Fridays for weight management when prescribed by a licensed provider.
• Longevity Program A telehealth wellness program focused on anti-aging and vitality, offering NAD+ injectable, Sermorelin, NAD+ liposomal liquid, MIC-B12, and NAD+ nasal spray to promote cellular repair, energy, lean muscle, and deeper sleep.
• Testosterone Replacement Therapy (TRT) A telehealth testosterone replacement therapy program offering Testosterone Cypionate (injectable) and Enclomiphene (oral), designed to optimize energy, sex drive, cognitive function, and mood. Includes a biomarker test kit for baseline testosterone measurement.
• GLP-1 Microdosing A lower-dose GLP-1 program offering microdose formulations of compounded Tirzepatide and Semaglutide, aimed at users seeking energy boosts, mental clarity, cravings management, and mood balance without full weight-loss dose regimens.

Quantifiable outcome

• Average weight loss of 9 lbs in first month for Fridays patients
• +3 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• OpenLoop Healthcare Partners, PCcoreStrategic or Co-development PartnerClinical services provider responsible for evaluating patient eligibility, prescribing GLP-1 medications, and providing telehealth consultations. Fridays' clinical services are provided by OpenLoop Healthcare Partners, PC and other affiliated networks. Providers retain full discretion to prescribe or decline compounded GLP-1 medications.
• Quest DiagnosticscoreImplementation/ SI/ Consulting PartnerLab testing services partner. Lab tests through Quest Diagnostics are fully covered as part of monthly subscription with no additional fees. Fridays members can visit Quest lab locations for comprehensive metabolic panels, hemoglobin A1C, thyroid panels, and lipid panels.
• RedRock PharmacycoreChannel Partner/ Reseller/ DistributorRegulated compounding pharmacy partner located in St. George, Utah. Produces and dispenses compounded GLP-1 medications prescribed through the Fridays platform. Subject to state pharmacy board regulations.
• Health WarehousecoreChannel Partner/ Reseller/ DistributorRegulated compounding pharmacy partner located in Florence, Kentucky. Provides compounded GLP-1 medication fulfillment services for Fridays patients.
• Precision MedicinecoreChannel Partner/ Reseller/ DistributorRegulated compounding pharmacy partner located in Bellmore, New York. Fulfills compounded GLP-1 prescriptions for Fridays patients in the Northeast region.
• Triad RxcoreChannel Partner/ Reseller/ DistributorRegulated compounding pharmacy partner located in Daphne, Alabama. Provides compounded GLP-1 medication fulfillment for Fridays patients.
• Friday Creators (Affiliate Program)minorGTM or Marketing PartnerCreator and affiliate marketing program (fridayscreators.com) enabling content creators to promote Fridays services. Includes dedicated landing pages for creator signups.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mochi Health: Mochi Health is a telehealth platform offering compounded and branded GLP-1 weight loss programs with bundled provider visits and support. It is one of the most direct head-to-head competitors to Fridays in the cash-pay GLP-1 category.
• Form Health: Form Health is a medical weight loss telehealth platform combining obesity medicine physicians with coaching and nutrition support. It competes with Fridays for the clinically managed, insurance-supported segment of the GLP-1 market.
• Henry Meds: Henry Meds is a DTC telehealth provider focused on compounded GLP-1 weight loss medications and hormone therapies. It targets the same cash-pay consumer seeking affordable telehealth access to semaglutide and tirzepatide.
• Hims & Hers Health: Hims & Hers is the largest publicly traded DTC telehealth platform in the US and a direct competitor to Fridays, offering branded and compounded GLP-1 weight loss alongside its broader men's and women's health portfolio. Both companies use a similar subscription, social-marketing-driven model targeting cash-pay and insured consumers.
• Found: Found is a DTC telehealth platform focused exclusively on medical weight loss using GLP-1 medications and lifestyle coaching. It targets a near-identical patient profile to Fridays and competes for the same keywords, creators, and cash-pay member base.
• Ro: Ro is a leading DTC telehealth company that operates a dedicated weight loss program (Ro Body) offering GLP-1 medications with bundled coaching and care. It mirrors Fridays' subscription architecture, prescriber network model, and reliance on social-led acquisition.
• LifeMD: LifeMD is a publicly traded telehealth company with a GLP-1 weight loss program (including compounded semaglutide) alongside broader primary care and men's/women's health verticals. It overlaps directly with Fridays' subscription GLP-1 model and cross-vertical bundling.
• Eden: Eden is a DTC telehealth platform offering compounded peptide and hormone therapies including GLP-1s, testosterone, and longevity peptides. It overlaps directly with Fridays' longevity, TRT, and microdosing verticals beyond core weight loss.

Broad incumbents

• Noom: Noom is an established behavior-change weight management platform that has added GLP-1 prescribing (Noom Med) to its psychology- and coaching-led core offering. It competes with Fridays at the intersection of lifestyle coaching and medication-assisted weight loss.
• WeightWatchers: WeightWatchers (via WeightWatchers Clinic, acquired from Sequence) is an incumbent weight management brand that has expanded into GLP-1 prescribing with bundled clinician support. It represents a broader incumbent alternative with stronger consumer brand equity and offline reach than Fridays.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@joinfridays
• Facebookfacebook.com/joinfridays
• Instagraminstagram.com/joinfridays
• TikToktiktok.com/@joinfridays
• LinkedInlinkedin.com/company/joinfridays

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fridays